Link Technologies appoints Swiss company as first partner in Europe
BELLSHILL, SCOTLAND, 3 September 2015: LINK (www.linktech.co.uk), the innovative developer and manufacturer of nucleic acid reagents, has announced the appointment of a new distributor in Switzerland - Chemie Brunschwig AG. This is LINK’s first formal partnership in Europe, and an important part of its strategy to strengthen Company representation in important market segments, thus increasing access to LINK’s range of innovative reagents for oligo therapeutics and diagnostics.
Chemie Brunschwig AG distributes over one million different chemicals, life science products and lab-ware to laboratories ranging from research and development to production in the Swiss market. Founded in 1948, the company has developed a wide R&D user base across industry, hospitals, private and public health labs, research centres, and universities.
Located in Basle, on the border to Germany and France in the Bio Valley, staff are able to communicate with customers in all three regional languages. Emmanuel Picard, Marketing & Sales Manager for Chemie Brunschwig, commented: “We are delighted to agree this partnership with LINK. It is an exciting opportunity to expand our portfolio of products, whilst playing a key role in driving LINK’s growth in the region.”
Dr David Ricketts, CEO of LINK, added: “In our home market of Europe, there are certain geographical areas where our customers can benefit from increased local representation due to factors such as language and purchasing regulations. It is essential therefore that we give these customers such a service. We have already developed a successful working relationship with Chemie Brunschwig, driving growth in Switzerland, and formally appointing them as our distributor was the next logical step. They are a company very much aligned to our ethos of quality and service, and we look forward to working with them to take our business forward.”
Editors’ Notes
About LINK
LINK, an ISO9001 certified manufacturer, is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification. The company’s main markets are university and commercial research departments, oligonucleotide synthesis companies, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.
LINK has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners. LINK is a trading name of Link Technologies Ltd, Scotland.
For further information see: www.linktech.co.uk
About Chemie Brunschwig AG
Since its foundation in 1948, Chemie Brunschwig AG has specialised in promoting and distributing throughout Switzerland over 1.5M fine chemicals and life sciences products to laboratories from industries (pharmaceutical, chemical, biotech, food, cosmetic, etc…), universities, hospitals, research centres and analytical labs. The Company’s products portfolio includes a wide range of organics/inorganics compounds, reagents, solvents and consumables for R&D, synthesis, production and analytics purposes.
Based in Basel, the company employs 20 people and has a reputation as a reliable distributor of high quality products and services, giving Swiss customers the benefit of its expertise and service by offering them the scientific, technical and/or financial solution that is most relevant for their needs. The Company daily leitmotiv is “we will never do enough for our customer, but let’s try…”.
For further information see: www.brunschwig-ch.com
Help employers find you! Check out all the jobs and post your resume.
